Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Unaudited Financial Results of ....
ABBOTINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Abbott India has informed BSE that its Board of Directors will meet on Thursday, February 12, 2026. The main agenda is to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025 (Q3 FY26 and 9M FY26). This is a standard advance intimation under SEBI Listing Regulations. No financial figures or outcomes have been disclosed yet; they will be released after the board meeting. The company's trading window for insiders remains closed from January 1, 2026, and will reopen 48 hours after the results are declared.
This filing does not move the stock — it is a routine pre-results notice. Investors should watch February 12, 2026 for the actual Q3 numbers, which could trigger short-term price action depending on performance versus expectations.